Benefits
Cortisol-Reducing Activity
RiaGev-FEM clinically proven to reduce cortisol levels in women — addresses cortisol-driven changes that often begin before first menopausal symptoms.
Faster Acting Than Other Cortisol-Lowering Ingredients
BLS positioning emphasizes shorter time to cortisol reduction than other ingredients in this category.
No Side Effects
Cortisol-lowering effects without typical side effects of cortisol-modulating ingredients.
Perimenopausal Applications
Specifically targets cortisol changes that occur well before first menopausal symptom — proactive perimenopausal support.
Versatile Combination Capability
Can be combined with other beneficial botanicals and bioactives for comprehensive women's health benefits.
Bioenergy Ribose + B3 Foundation
Built on BLS's RiaGev foundation (NAD+ and ATP support) with women-specific applications.
Mechanism of action
Cortisol Pathway Modulation
Specific mechanism for cortisol reduction in women — BLS proprietary research.
Bioenergy Ribose Energy Support
D-ribose component supports cellular ATP — relevant to fatigue often accompanying hormonal changes.
Niacinamide NAD+ Support
Vitamin B3 component supports NAD+ — relevant to cellular energy and aging.
Women-Specific Formulation
Tailored for women's specific hormonal/cortisol patterns vs general RiaGev.
Clinical trials
BLS clinical evaluation of RiaGev-FEM specifically in women.
Women including perimenopausal.
Cortisol reduction; women's wellness markers.